References
- Kawaguchi K, Fujii S, Konishi I et al. Ultrastructural study of cultured smooth muscle cells from uterine leiomyomas and myometrium under the influence of sex steroids. Gynecol Oncol 1985; 21: 34–41.
- Kanetoshi K, Shingo F, Ikuo K et al. Immunohistochemical analysis of estrogen receptors, progesterone receptors and ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchows Archiv A Pathol Anat 1991; 419: 309–15.
- Gerdes J, Lelle RJ, Pickartz H. Growth fraction in breast cancer determined in situ with the monoclonal antibody ki-67. J Clin Pathol 1986; 39: 977–80.
- Kubota Y, Petras RE, Easley KA et al. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer 1992; 70: 2602.
- Bosman FT, Visser BC, Oeveren JV Apoptosis: Pathophysiology of programmed cell death. Pathol Res Pract 1996; 192: 676–83.
- Lowe SW, Schmitt EM, Smith SW et al. P53 is required for radiation induced apoptosis in mouse thymocytes. Nature 1993; 362: 847–9.
- Zhai YL, Kobayashi Y, Mori A et al. Expression of steroid receptors, ki-67 and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 1999 Jan; 18(1): 20–8.
- Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493–501.
- Gerdes J, Lemke H, Baisch H et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody ki-67. J Immunol 1984; 133: 1710–15.
- Hall PA, Levison DA. Assessment of cellular proliferation in histological material. J Clin Pathol 1992; 43: 184–92.
- Kanetoshi K, Shingo F, Ikuo K et al. Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol 1989; 160: 637–41.
- Takahiro M, Ayako S, Karo N, Nobuyuki T. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (Leuprolide acetate). J Clin Endocrinol Metab 1998; 83: 1253–5.
- Brandon DD, Bethea CL, Strawn EY et al. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol 1993; 69: 78–85.
- Brandon DD, Erickson TE, Keenan EJ et al. Estrogen receptor gene expression in human uterine leiomyoma. J Clin Endocrinol Metab 1995; 80: 1876–81.
- Englund K, Blanck A, Gustavsson I et al. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and treatment with gonadotropin-releasing hormone analogue. J Clin Endocrinol Metab 1998; 83(11): 4092–6.
- Sadan O, van Iddekinge B, Savage N et al. Endocrine profile associated with estrogen and progesterone receptors in leiomyoma and myometrium. Gynecol Endocrinol 1991; 4: 33–42.
- Murphy AA, Kettle M, Morales AJ et al. Regression of uterine leiomyomata in response to the antiprogesterone RU486. J Clin Endocrinol Metab 1993; 76: 513–17.
- Tiltman AJ. The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol 1985; 4: 89–96.
- Boehm KD, Daimon M, Gorodeski IG. Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol Reprod Dev 1990; 27: 93–101.
- Ghahary A, Chakrabarti S, Murphy LH. Localization of the sites of synthesis and action of insulin-like growth fac- tor-I in the rat uterus. Mol Endocrinol 1990; 4: 191–5.
- Wang XN, Sanjoy KD, Deborah D et al. Differential regulation of heparin-binding epidermal growth factor-like growth factor in the adult ovariectomized mouse uterus by progesterone and estrogen. Endocrinology 1994; 135: 1264–71.
- Rotello RJ, Hocker MB, Gerschenson LE. Biochemical evidence of programmed cell death in rabbit uterine epithelium. Am J Pathol 1989; 134: 491–5.
- Anderson TJ, Ferguson DJP, Raab GM. Cell turnover in the ‘resting’ human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 1982; 46: 376–82.
- Soini Y, Pääkkö P Bcl-2 is preferentially expressed in tumors of muscle origin but is not related to p53 expression. Histopathology 1996; 28: 141–5.
- Patterson H, Gil S, Fisher C et al. Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas. Br J Cancer 1994; 69: 1052–8.